In this second part of a series on the state of clinical research, a leader from Javara lays out ideas to bring clinical research and care closer together.
In this first part of a series on the state of clinical research, an expert shares insightful ideas on how to improve patient experience and study results.
With global health care ‘at a tipping point,’ NSF International expands its services across the product lifecycle with the acquisition of a US-headquartered CRO, says VP.
GE Healthcare’s Edison platform collaborates with ACR AI-Lab to extend its AI capabilities and allows ACR members access to algorithm creation in an aim to turn research into product development.
BlueCloud by HealthCarePoint releases DDIT mechanisms to create an Uber-like service for the health care industry – connecting providers and consumers, such a sponsors and CROs.
The goal of the learning health system is to improve based on the experiences of every participant, sharing research knowledge to drive a “person-centered future of health,” says LHC CEO.
Why do people do what they do? This is the question behavioral science aims to answer – and our understanding of which is directly relevant to the challenges facing the health care industry, says industry expert.
Access to an increasing amount of information is catalyzing research, while also lending to higher levels of professional burnout on behalf of health care professionals, says company executive.
In the era of big data, the industry is working to address the ethical concerns of integrating patient information into the health care landscape – though a key challenge will be reaching a consensus on what constitutes reliable evidence.
Integrating clinical research into the health care ecosystem improves patient engagement and quality of care while reducing costs, though only 1% of the general population participates in clinical trials.
Clinical research’s sordid past has “left a stain” on the medical community as it tries to gain trust among minority populations and increase clinical trial participation, which remains staggeringly low, says Northwell Health senior VP.
Avista Capital Partners has signed an agreement to acquire United BioSource (UBC), adding another pharmaceutical service provider to the firm’s list of current and historical investments.
Lack of trust has become less of a barrier to clinical trial participation, though more work needs to be done as information access and service levels receive low marks in a recent survey.
Researchers conducting smoking cessation clinical trials should use biochemical measures to determine if participants have quit – as many falsely self-report, according to a recent study.
UDG Healthcare has acquired Cambridge BioMarketing LLC in a deal worth up to $35m as the healthcare service provider looks to continue expansion in the United States.
The renewed contract covers a range of research related services, including monitoring therapeutic trials, prevention trials, and vaccines work, with the ultimate goal of an "AIDS-free generation."
UDG’s Ashfield division will use Salesforce Health Cloud to help outsource clients launch therapies into EU and US markets through “seamless” data exchange.
Poor communication between healthcare providers and clinical research professionals is contributing to low recruitment rates, according to a recent study by Tufts.
The “Bring Your Own Device” (BYOD) continues to gain momentum with ERT’s acquisition of Exco InTouch, a provider of patient engagement, data capture, and digital health solutions.
Exco InTouch has been granted a US patent for to its mobile health solutions, as the company works to establish its “leadership in the digital health field.”
Validic and Sutter Health are collaborating on a federal pilot project that seeks to determine how patient-generated health data can be best delivered to researchers.
Clinical trial data sharing continues to be a contentious topic in the industry, so in an attempt to demonstrate its potential, the New England Journal of Medicine (NEJM) is sponsoring the SPRINT Data Analysis Challenge.
The Precision Medicine Initiative (PMI) Cohort Program is expected to launch later this year with the goal of enrolling more than one million US participants by 2020.
On the heels of a new study, which found that Allergan's Waco operations generated an economic impact of $263m on the area’s income, the city is hoping for new expansion.
The Coalition for Clinical Trials Awareness (CCTA) has called for a federally-supported public health campaign to make people more aware of drug research and the value of participating in studies.
Drug, vaccine and medical device developers should publish all trial results according to the WHO, which says anything less skews R&D priorities and public healthcare investment.
Further evidence US diabetics pay more for drugs than sufferers in comparable countries has emerged this month in a study assessing the diseases’ economic impact.
A new California bill introduced earlier this week would, for the first time, require pharma companies to unveil a number of unique operational costs as a way to better understand drug pricing.
The National Institute for Health Research (NIHR) Clinical Research Network, which provides more than £284m ($475m) a year to support the delivery of clinical research studies, has reconfigured to become 15 local clinical research networks across England.
CRO inVentiv on Monday announced a joint venture with the partners of the US lobbying firm Mehlman Vogel Castagnetti to help pharma companies further understand the health policy and regulatory landscape.
